VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Patient has been fully informed and has signed an  │ Patient has been fully informed and has signed an  │     100 │
│ IRB approved informed consent form within 7 days   │ IRB approved informed consent form within 7 days   │         │
│ (Day 7-13) prior to POD 15 and is willing and able │ (Day 7-13) prior to POD 15 and is willing and able │         │
│ to follow study procedure                          │ to follow study procedure                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient is a primary liver transplant recipient    │ Patient is a primary liver transplant recipient    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient is 20 to 70 years of age                   │ Patient is 20 to 70 years of age                   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient should be clearly conscious, fully         │ Patient should be clearly conscious, fully         │     100 │
│ understand and able to answer questionnaire        │ understand and able to answer questionnaire        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient has previously received or is receiving an │ Patient has previously received or is receiving an │     100 │
│ organ transplant other than a liver                │ organ transplant other than a liver                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient currently requires dialysis                │ Patient currently requires dialysis                │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Recipient or donor is known to be seropositive for │ Recipient or donor is known to be seropositive for │     100 │
│ human immunodeficiency virus (HIV)                 │ human immunodeficiency virus (HIV)                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient has received a liver transplant from a     │ Patient has received a liver transplant from a     │     100 │
│ non-heart beating donor                            │ non-heart beating donor                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient who is HCV negative has received an HCV    │ Patient who is HCV negative has received an HCV    │     100 │
│ positive (HCV RNA by PCR or HCV antibody) donor    │ positive (HCV RNA by PCR or HCV antibody) donor    │         │
│ liver                                              │ liver                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient who is HbsAg negative has received an      │ Patient who is HbsAg negative has received an      │     100 │
│ HbsAg positive (HBV DNA by PCR or HBV antibody)    │ HbsAg positive (HBV DNA by PCR or HBV antibody)    │         │
│ donor liver                                        │ donor liver                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient has a current malignancy or a history of   │ Patient has a current malignancy or a history of   │     100 │
│ malignancy (within the past 5 years), except       │ malignancy (within the past 5 years), except       │         │
│ hepatocellular carcinoma within UCSF Criteria and  │ hepatocellular carcinoma within UCSF Criteria and  │         │
│ basal or non-metastatic squamous cell carcinoma of │ basal or non-metastatic squamous cell carcinoma of │         │
│ skin that has been treated successfully            │ skin that has been treated successfully            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient is hemodynamically unstable on POD 15      │ Patient is hemodynamically unstable on POD 15      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient has received a liver transplant from a     │ Patient has received a liver transplant from a     │      99 │
│ decrease donor \> 70 years of age                  │ decrease donor > 70 years of age                   │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                    │   Score │
╞═══════════════════════════════════╪══════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Patient is 20 to 70 years of age │      40 │
├───────────────────────────────────┼──────────────────────────────────┼─────────┤
│ Must have maximum age of 70 Years │ Patient is 20 to 70 years of age │      46 │
╘═══════════════════════════════════╧══════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 92.33333333333333
OverAll Ratio: 94.66666666666666
